Samuelle Fajutrao Falk
Samuelle Fajutrao Falk writes about autism, genetic research and research ethics from the combined perspective of a practicing psychiatrist and early-career researcher. Her coverage focuses on how autistic people and their families experience genetic studies, stressing trust, data use and the historical weight of eugenics rather than the science alone. She brings clinical and research experience into accessible pieces for The Conversation that foreground the voices and concerns of research participants.
Autism, genetics and research participation
At The Conversation, Fajutrao Falk’s work centres on autistic people’s attitudes to genetic research and what shapes their support or resistance. In her article on autistic perspectives on genetic studies, she reports findings from a project where she and her colleagues asked autistic people and parents of autistic children in Sweden how they felt about genetic research. She explains that most respondents supported research and many wanted more of it, but they were deeply concerned about how scientists might use genetic data and what consequences those uses could have for autistic people.
Her coverage treats autistic participants and parents as experts on their own lives rather than passive subjects, drawing directly on their responses about trust, consent and future applications of research. She writes about recruitment processes that involve a digital conversation of 30–60 minutes with parents of children with autism, reflecting her hands-on role in studies that explore expectations and worries around genetic work. Across this reporting, she keeps the focus on participation: who is asked, what they are told, and how their views should shape the design and governance of health research.
Eugenics, stigma and the ethics of genetic data
Fajutrao Falk consistently situates autism genetics within the broader historical and ethical context of eugenics. In her analysis for The Conversation, she addresses the fear that genetic information could be used to justify selective reproduction or policies aimed at preventing autistic people from being born, rather than improving support and understanding. She describes how respondents in her study worry about scientists or policymakers using genetic findings to reinforce stigma, frame autism as a defect, or prioritize eradicating traits over accommodating differences.
Her writing draws a clear line between supporting research and rejecting eugenic applications, showing that many autistic people and parents differentiate between knowledge generation and the social uses of that knowledge. She highlights concerns about who controls genetic data, how findings are communicated to the public, and what safeguards are needed to prevent discrimination based on genetic risk or diagnosis. By anchoring current debates in the history of eugenics and contemporary disability politics, she offers communications that speak to both scientific and social audiences on health research ethics.
Clinical psychiatry and lived experience
Fajutrao Falk’s perspective is shaped by her work as a medical doctor specializing in adult psychiatry and her position as a PhD candidate at Karolinska Institutet. This dual role underpins coverage that connects formal diagnoses, treatment pathways and research agendas with lived experience and everyday concerns expressed by autistic people and their families. She writes as someone actively involved in recruiting and interviewing parents of autistic children for studies about genetic research, bringing first-hand insight into how families understand risk, benefit and trust in medical institutions.
Her pieces emphasise relational aspects of health research: how clinicians communicate, how researchers listen, and how those interactions shape whether people feel respected and safe when sharing genetic and health information. She is attentive to the impact of language used around autism and genetics, and to the way explanations offered in psychiatric and research settings can either validate autistic identities or contribute to pathologising them. Taken together, her body of work presents a psychiatry-informed, participant-centred view of health research that is grounded in empirical studies and in ongoing conversations with autistic communities.
4 more health journalists.
Abida Tasnim
Abida Tasnim is a health writer for The Daily Star who focuses on clear, practical guidance that helps readers recognise risks early and act before everyday illnesses turn into wider public health problems. She reports on infectious disease prevention, using measles coverage to show how outbreaks start with individual decisions and behaviours, not just hospital statistics. Her work explains what happens during an outbreak and then anchors the story in simple steps people can take, such as avoiding crowded places when symptoms appear, practising good hygiene, and seeking medical advice early. She writes direct, action‑oriented health explainers that turn clinical questions about contagion and disease burden into everyday choices. Across her beat, she stresses early recognition, timely care, and prevention as the foundations of healthier communities.
Adrián Carballo Casla
Adrián Carballo Casla stands out for turning complex cohort data on ageing into clear, food‑level advice on what older adults should eat to protect brain health and slow chronic disease. He is a researcher in nutritional epidemiology focused on ageing and chronic disease prevention and a postdoctoral researcher in geriatric epidemiology at Karolinska Institutet, writing health explainers for The Conversation. He reports on how diet quality, especially Mediterranean and Mind‑style patterns, shapes dementia risk, grey matter loss and neurocognitive ageing, and how healthy versus pro‑inflammatory diets alter multimorbidity trajectories. His articles translate findings on flavonoids, polyphenols, folate, omega‑3 fats and dietary nitrates into specific food choices and small, practical changes. Much of his coverage is anchored in his own studies on multimorbidity, high‑risk older adults and tailored dietary recommendations, often syndicated to other outlets.
Ahmed Elbediwy
Ahmed Elbediwy brings a lab-based understanding of cancer biology and clinical biochemistry to public-facing health reporting, linking drug mechanisms and molecular pathways to everyday choices about medicines and products. He writes for The Conversation on weight-loss injections, cancer overdiagnosis and anti-ageing supplements, focusing on obesity medicine, cancer signalling, screening trade-offs, skincare and supplement science. His pieces on GLP-1 drugs such as Ozempic, Wegovy and Mounjaro explain why some people do not respond, how gut hormones and appetite signals work, and where psychological support and nutrition fit alongside prescriptions. He co-authors explainers on cancer risk and overdiagnosis and on whether supplements can reverse ageing, separating established knowledge from emerging research. An award-winning senior lecturer at Kingston University, he favours clear, structured explainers, careful definition of key terms and evidence-based appraisal over hype.
Amanda Sheppeard
Amanda Sheppeard is a managing editor and health journalist known for long, detailed explainers that connect complex clinical research, disability policy and political narratives with the daily realities of doctors and patients. She works at The Medical Republic across editorial leadership and commercial content while reporting widely on medicine for its specialist titles. Her real beat spans autism, disability policy, autoimmune disease, infectious threats and system pressures in primary care and hospitals. She covers subjects such as autism diagnosis and the NDIS, rheumatology’s clinical shifts, weight-loss agents in rheumatoid arthritis, infection control, antimicrobial resistance and new modalities like CAR T-cell therapy and microneedles. She reports by doing the synthesis inside the story, linking trial design, molecular targets, funding rules and policy changes to concrete decisions and workflows in clinics and hospitals.